Chronic oral mucosal ulceration in a 54-year-old female

Annals of Allergy, Asthma and Immunology

Volumn 84, Issue 4, 2000, Pages 391-395

  Chiang, Hsien ^a   Sirois, David A ^b,c   Bielory, Leonard ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^b RUTGERS SCHOOL OF DENTAL MEDICINE   (United States)

^c UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; ANTINUCLEAR ANTIBODY; AZATHIOPRINE; C REACTIVE PROTEIN; DAPSONE; DEXAMETHASONE; METHYLPREDNISOLONE SODIUM SUCCINATE; MYCOPHENOLIC ACID; PREDNISONE;

ADULT; ARTICLE; BIOPSY; CASE REPORT; FEMALE; HEMOLYSIS; HUMAN; MOUTH MUCOSA; MOUTH ULCER; PEMPHIGUS VULGARIS; PRIORITY JOURNAL;

EID: 0033993417     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)62270-3     Document Type: Article

References (31)

1. Lever WF. Pemphigus and pemphigoid. Springfield, IL: Charles C Thomas Publisher, 1965.
2. Fine JD. Management of acquired bullous skin diseases. N Engl J Med 1995; 333:1475-1484.
3. Bastuji-Garin S, Souissi R, Blum L, et al. Comparative epidemiology of pemphigus in Tunisia and France. J Invest Derm 1995;104.
4. Kyrakis K, Tosca A, Lehou J, et al. A five year retrospective study on pemphigus and pemphigoid. Australas J Dermatol 1989;30:33-36.
5. Bystryn J-C, Steinman NM. The adjuvant therapy of pemphigus: an Update. Arch Dermatol 1996;132:203-212.
6. Pisanti S, Sharrow V, Kaufman E, Pesner LN. Pemhigus vulgaris: incidence in Jews of different ethnic groups according to age, sex and initial lesion. Oral Surg 1974;38:382-387.
7. Eversole LR, Kenney EB, Sabes WR. Oral lesions as the initial sign in pemphigus vulgaris. Oral Surg Oral Med Oral Pathol 1972;33:354-361.
8. Lamey PJ, Rees TD, Binnie WH, et al. Oral presentation of pemphigus vulgaris and its response to systemic steroid therapy. Oral Surg Oral Med Oral Pathol 1992;74:54-57.
9. Robinson JC, Lozada-Nur F, Frieden I. Oral pemphigus vulgaris: a review of the literature and a report on the management of 12 cases. Oral Surg Oral Med Oral Pathol 1997;84:349-355.
10. Sirois DA, Leigh J, Sollecito T. Oral pemphigus vulgaris preceding cutaneous lesions: recognition and diagnosis by the dentist. J Am Dent Assoc (in press).
11. Ettlin D, Sirois DA. Diagnostic patterns in pemphigus vulgaris depending on the site of initial presentation. Arch Dermatology (in press).
12. Buhac J, Bhol K, Padilla T, et al. Coexistence of pemphigus vulgaris and ocular cicatricial pemphigoid. J Am Acad Dermatol 1996;34:884-886.
13. Scricca JM, Alper JC. Pathological case of the month. Arch Pediatr Adolesc Med 1997;151:627-628.
14. Habif TP. Clinical dermatology. 3rd ed. St. Louis, MO: Mosby-Year Book, 1996.
15. Scott JE, Ahmed AR. Office dermatology, Part II. The blistering diseases. Med Clin North Am 1998;82: 1239-1283.
16. Brenner S, Bialy-Golan A, Grant A. Clinical and laboratory studies: recognition of pemphigus antigens in drug-induced pemphigus vulgaris and pemphigus foliaceus. J Am Acad Dermatol 1997;36:919-923.
17. Daniels TE. Diseases of the mouth and salivary glands. In: Bennett JC, Plum F, eds. Cecil textbook of medicine, 20th ed. Philadelphia, PA: WB Saunders; 1996:645-650.
18. Parker F. Skin diseases of general importance. In: Bennett JC, Plum F, eds. Cecil textbook of medicine, 20th ed. Philadelphia, PA: WB Saunders; 1996: 2197-2220.
19. Gay RM, Ball BV. Vasculitis. In: Koopman WJ, ed. Arthritis and allied conditions, 13th ed. Baltimore, MD: Williams & Wilkins, 1997:1496-1497.
20. Drago F, Parodi A, Rebora A. Persistent erythema multiforme: report of two new cases and review of literature. J Am Acad Dermatol 1995;33: 366-369.
21. Kastner DL. Intermittent and periodic arthritic syndromes. In: Koopman WJ, ed. Arthritis and allied conditions, 13th ed. Baltimore, MD: Williams & Wilkins, 1997;1291-1297.
22. Rees TD, Binnie WH. Disorders affecting the oral cavity: recurrent aphthous stomatitis. Dermatol Clin 1996; 14:243-252.
23. Mourello O, Chaidemenos CG, Koussidou TH, Kapetis E. The treatment of pemphigus vulgaris. Experience with 48 patients seen over an 11 year period. Br J Dermatol 1995;133: 83-87.
24. Mashkilleyson N, Mashkilleyson AL. Mucous membrane manifestations of pemphigus vulgaris: a 25 year study of 185 patients treated with corticosteroids or with a combination of corticosteroids with methotrexate or heparin. Acta Derm Venereol (Stokh) 1988;68: 413-421.
25. Rosenberg FR, Sanders S, Nelson CT. Pemphigus: a 20 year review of 107 patients treated with corticosteroids. Arch Dermatol 1976;112:962-970.
26. Brystyn JC. Adjuvant therapy of pemphigus. Arch Dermatol 1984;120:941.
27. Chryssomallis F, Dimitriades A, Chaidemenos G, et al. Steroid pulse therapy in pemphigus vulgaris long term follow up. Int J Dermatol 1995; 34:438-442.
28. Aberer W, Wollf-Schreiner EG, Stinge G, Wollf K. Azothioprine in the treatment of pemphigus vulgaris. J Am Acad Dermatol 1987;16:527-533.
29. Pandya AG, Sontheimer RD. Treatment of pemphigus vulgaris with pulse intravenous cyclophosphamide. Arch Dermatol 1992;128:1626-1630.
30. Enk AH, Knop J. Mycophenolate is effective in the treatment of pemphigus vulgaris. Arch Dermatol 1999;135: 54-61.
31. Jolies S, Huges J, Whittaker S. Dermatological uses of high-dose intravenous immunoglobulin. Arch Dermatol 1998;134:80-86.